Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas

作者: S Balesaria , C Brock , M Bower , J Clark , S K Nicholson

DOI: 10.1038/SJ.BJC.6693403

关键词:

摘要: Loss of heterozygosity (LOH) for chromosome 10 is the most frequent genetic abnormality observed in high-grade gliomas. We have used fluorescent microsatellite markers to examine a series 83 patients, 34 with anaplastic astrocytoma (grade 3) and 49 glioblastoma multiforme 4), LOH 10. Genotype analysis revealed all informative 12 (35%) patients grade 3 29 (59%) 4 tumours respectively, while partial was found further eight (24%) ten (20%) tumours. Partial LOH, confined long arm (10q) six short (10p) three cases, alleles from both arms were lost four cases. Five (one 4) showed heterogeneity respect loss at different loci. There correlation between any poorer performance status presentation (chi2 P = 0.005) increasing age diagnosis (Mann-Whitney U-test 0.034) but not tumour p= 0.051). A Cox multivariate model survival duration identified (proportional hazards (PH), P= 0.004), (PH, 0.012) 0.009) as only independent prognostic variables. Specifically, able identify subgroup who had significantly shorter time. conclude that an independent, adverse variable glioma.

参考文章(38)
M Brada, JW Ironside, SP Stenning, PL Lantos, JT Roberts, F Senanayake, Dgt Thomas, JB Whaley, P Abram, Tmrcbtwp for, NM Bleehen, TH Moss, Medical Research Council (MRC) randomised trial of adjuvant chemotherapy in high grade glioma (HGG)- BR05. In: (pp. 400a (1543-). (1998). ,(1998)
McLendon Re, Bigner Dd, Fuchs He, Friedman Ah, Rasheed Bk, Bigner Sh, Friedman Hs, Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25. Oncogene. ,vol. 10, pp. 2243- 2246 ,(1995)
Jin Jen, J Wade Harper, Sandra H Bigner, Darell D Bigner, Nickolas Papadopoulos, Sanford Markowitz, James KV Willson, Kenneth W Kinzler, Bert Vogelstein, None, Deletion of p16 and p15 Genes in Brain Tumors Cancer Research. ,vol. 54, pp. 6353- 6358 ,(1994)
David R. Cox, Regression Models and Life-Tables Springer Series in Statistics. ,vol. 34, pp. 527- 541 ,(1992) , 10.1007/978-1-4612-4380-9_37
Guido Reifenberger, Ghazaleh Tabatabai, Marietta Wolter, J. M. J. Ludwig Cobbers, V. Peter Collins, Peter Lichter, Ruthild G. Weber, Jan Boström, Mutation of the PTEN (MMAC1) Tumor Suppressor Gene in a Subset of Glioblastomas but not in Meningiomas with Loss of Chromosome Arm 10q Cancer Research. ,vol. 58, pp. 29- 33 ,(1998)
Nikolai G. Rainov, Karl-Ulrich Dobberstein, Hannes Bahn, Hans-Jürgen Holzhausen, Christine Lautenschläger, Volkmar Heidecke, Winfried Burkert, Prognostic factors in malignant glioma: Influence of the overexpression of oncogene and tumor-suppressor gene products on survival Journal of Neuro-oncology. ,vol. 35, pp. 13- 28 ,(1997) , 10.1023/A:1005841520514
Paola Campomenosi, Laura Ottaggio, Francesca Moro, Stefania Urbini, Massimo Bogliolo, Annalisa Zunino, Annalisa Camoriano, Alberto Inga, Salvatore L. Gentile, Natalia S. Pellegata, Stefano Bonassi, Eros Bruzzone, Raffaella Iannone, Roberto Pisani, Paola Menichini, Guglielmina N. Ranzani, Stefania Bonatti, Angelo Abbondandolo, Gilberto Fronza, Study on aneuploidy and p53 mutations in astrocytomas. Cancer Genetics and Cytogenetics. ,vol. 88, pp. 95- 102 ,(1996) , 10.1016/0165-4608(95)00359-2
David N. Louis, James F. Gusella, A tiger behind many doors : multiple genetic pathways to malignant glioma Trends in Genetics. ,vol. 11, pp. 412- 415 ,(1995) , 10.1016/S0168-9525(00)89125-8
Julie M. Cunningham, David W. Kimmel, Bernd W. Scheithauer, Judith R. O'Fallon, Paul J. Novotny, Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: relationships and prognostic value. Journal of Neurosurgery. ,vol. 86, pp. 121- 130 ,(1997) , 10.3171/JNS.1997.86.1.0121
E.S. Newlands, S.M. O'Reilly, M.G. Glaser, M. Bower, H. Evans, C. Brock, M.H. Brampton, I. Colquhoun, P. Lewis, J.M. Rice-Edwards, R.D. Illingworth, P.G. Richards, The Charing Cross Hospital experience with temozolomide in patients with gliomas. European Journal of Cancer. ,vol. 32, pp. 2236- 2241 ,(1996) , 10.1016/S0959-8049(96)00258-4